| Date Filed | Type | Description |
| 08/23/2023 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 9,328 shares
@ $107.3988, valued at
$1M
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/08/2023 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,040 shares
@ $105.6772, valued at
$321.3k
Sold 3,248 shares
@ $102.2985, valued at
$332.3k
Sold 20,482 shares
@ $102.4338, valued at
$2.1M
Sold 2,274 shares
@ $104.3028, valued at
$237.2k
|
|
| 02/02/2023 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,707 shares
@ $110.0839, valued at
$298k
|
|
| 06/27/2022 |
4
| GORMAN KEVIN CHARLES (Director) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 21,412 options to buy
@ $26.58, valued at
$569.1k
|
|
| 02/09/2022 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,422 shares
@ $80.8252, valued at
$195.8k
Sold 3,248 shares
@ $80.8245, valued at
$262.5k
Sold 3,040 shares
@ $80.7994, valued at
$245.6k
Sold 2,274 shares
@ $79.4932, valued at
$180.8k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2020 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,390 shares
@ $90.781, valued at
$307.7k
|
|
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| GORMAN KEVIN CHARLES (Director) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 13,953 options to buy
@ $33.42, valued at
$466.3k
|
|
| 04/28/2020 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,906 shares
@ $99.4548, valued at
$289k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,027 shares
@ $103.0832, valued at
$312k
Sold 2,422 shares
@ $103.0937, valued at
$249.7k
Sold 4,343 shares
@ $101.5583, valued at
$441.1k
Granted 145,698 options
@ $102.9, valued at
$15M
Granted 23,081 restricted stock units
@ $0 |
|
| 08/13/2019 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Exercised 3,031 options to buy
@ $32.99, valued at
$100k
|
|
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2018 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Exercised 23,168 options to buy
@ $5.76, valued at
$133.4k
Exercised 16,551 options to buy
@ $8.66, valued at
$143.3k
Exercised 10,199 options to buy
@ $8.65, valued at
$88.2k
Exercised 7,142 options to buy
@ $19.59, valued at
$139.9k
Exercised 864 options to buy
@ $32.99, valued at
$28.5k
|
|
| 06/27/2018 |
4
| GORMAN KEVIN CHARLES (Director) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 7,500 options to buy
@ $38.93, valued at
$292k
|
|
| 05/03/2018 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 126,832 shares
@ $80.7504, valued at
$10.2M
Exercised 126,832 options to buy
@ $5.76, valued at
$730.6k
|
|
| 02/07/2018 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,125 shares
@ $83.0787, valued at
$259.6k
Sold 2,858 shares
@ $83.465, valued at
$238.5k
Sold 100,000 shares
@ $80.0662, valued at
$8M
Paid exercise price by delivering 4,091 shares
@ $82.48, valued at
$337.4k
Exercised 100,000 options to buy
@ $5.76, valued at
$576k
Granted 104,200 options
@ $81.49, valued at
$8.5M
Granted 18,400 restricted stock units
@ $0 |
|
| 01/18/2018 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,750 shares
@ $78.8853, valued at
$295.8k
|
|
| 06/26/2017 |
4
| GORMAN KEVIN CHARLES (Director) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 7,500 options to buy
@ $22.2, valued at
$166.5k
|
|
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/17/2017 |
4
| GORMAN KEVIN CHARLES (Director) has filed a Form 4 on Xencor Inc |
| 04/17/2017 |
3
| GORMAN KEVIN CHARLES (Director) has filed a Form 3 on Xencor Inc |
| 04/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|